Archives: Profiles

Lone Knudsen Krogsbøll

Lone Knudsen Krogsbøll

Lone Krogsbøll manages Medical Cannabis Fyn, a cluster connecting the industry, suppliers, science and research within medical cannabis, to ensure growth in the sector, and make the most of Denmark’s position as European frontrunner.

Michael Garbuz

Michael Garbuz

Michael Garbuz is co-founder and President of Materia Venturesa. As a corporate lawyer and business strategist, who founded Vision Advisory Inc. in 2018. Prior to founding Materia Ventures, Michael founded Vision Advisory, a corporate advisory ad investment firm. He also held a corporate strategy and legal counsel role with Origin House (CSE:OH) (formerly, CannaRoyalty) and was a founding shareholder and advisor of Trichome Financial.

Narbé Alexandrian

Narbé Alexandrian

Narbé Alexandrian’s experience working in the most cutting-edge technology companies, as well as his background in financial consulting, brought him to Canopy Rivers, where he acts as President and CEO. Narbé is also a university instructor where he shares his knowledge to undergraduate and MBA students.

Matei Olaru

Matei Olaru

"Matei Olaru is the CEO of Lift Co., Canada's leading cannabis media,
technology and product platform. A corporate lawyer and consultant by trade, Matei
practiced law for the cannabis industry working with the Marihuana for Medical
Purposes Regulations (MMPR) before joining Lift in 2016. Prior to that, Matei helped
advise governments on business and investment policy as a consultant with the World
Bank (IFC). He holds a law degree and a business degree, and has studied internationally
in Italy and Singapore."

Paul North

Paul North

Paul is a criminologist and addiction specialist with nine years experience working in the drug treatment sector. During this time he managed services, delivered bespoke addiction training programmes for the public sector and lectured at Universities. Alongside his Volteface work, Paul is a Director at Drugs and Me, a social enterprise that provides services centered around drug harm reduction.

Pierre Vannineuse

Pierre Vannineuse

Pierre Vannineuse is the founder and CEO of Alpha Blue Ocean and manages the investment strategy of the firm. Before Blue Ocean, Pierre was founder and CEO of the family office Bracknor. He started his career in the energy industry, at the Finance department of the world renown oil company Total, before moving on to M&As at Engie.

Olga Bequerença

Olga Bequerença

Olga Bequenreça is Head of Investment at AICEP Portugal Global, the country's foreign investment agency. As such, she helps American and Canadian companies understand the Portuguese economic landscape and identify the right opportunities to invest in the countries. In recent years, her focus has incresingly been on advising North American cannabis companies who were looking for the right partners to establish a presence in the Portuguese market.

Blair Gibbs

Blair Gibbs

Blair Gibbs is public policy consultant and government relations advisor based in Canada. He specialises in policy, regulations and political developments affecting legal cannabis markets.

Dean Billington

Dean Billington

Dean is the Chief Science Officer at Brains Bioceuticals. Dean is a consultant with a proven track record in providing comprehensive support services to all areas of the Pharmaceutical.

Roland Harwood

Roland Harwood

Roland Harwood is founder of Liminal, a new network for people, organisations and communities on the edge of many potential futures.

José Ricardo

José Ricardo

José Ricardo Puyana is Minister Counsellor for Political and Economic Affairs at the Colombian Embassy to the UK.

Camilla Horsfall

Camilla Horsfall

Camilla Horsfall is a Director at Blytheweigh, a boutique London financial PR Firm and one of the leading for cannabis stocks.

Tom Powell

Tom Powell

Tom Powell is the current SVP of Corporate Affairs for Jacana, a former venture capitalist with 5 years experience in financial services and a former HM Treasury InsurTech board member.

Lewis Cameron

Lewis Cameron

Head of Research & Development, Medcann Pharma With more than 25 years in preclinical and clinical drug development, Lewis Cameron serves as the Head of Research & Development at Medcann Pharma.

Anne Schlag

Anne Schlag

Dr Anne Katrin Schlag is Head of Research at DrugScience and Honorary Fellow at Imperial College London.

Henry Fisher

Henry Fisher

Dr Henry Fisher is a co-founder and Chief Scientific Officer of Hanway Associates, London’s global cannabis consultancy.

Diana Gutiérrez

Diana Gutiérrez

Diana Gutiérrez has more than 15 years experience in pharmaceutical industry in various positions in the Quality field.

Leigh Hughes

Leigh Hughes

Leigh is an integrated marketing communications and innovations professional of 15+ years.

Robert Cookson

Robert Cookson

Robert Cookson is a consultant at Hanway Associates. He advises companies on how to enter and build their businesses in Europe's legal cannabis markets.

Alexandra Curley

Alexandra Curley

Alexandra is Head of Insights at Prohibition Partners, providing market data and intelligence to key stakeholders in the industry.

  • 1
  • 2
  • 6